Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04651959
What this trial is testing

Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions

Who this might be right for
Bioequivalence
Pharma Plant 30
Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Large-scale testing (Phase 3)Study completedNCT00002436
What this trial is testing

The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

Who this might be right for
HIV Infections
Glaxo Wellcome 325
Post-approval studies (Phase 4)Study completedNCT02734173
What this trial is testing

Pilot HCV Direct Acting Antiviral Therapy and Metabolism

Who this might be right for
Hepatitis C
Ottawa Hospital Research Institute 24
Early research (Phase 1)Study completedNCT01700179
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants

Who this might be right for
Chronic Hepatitis C Infection
Alexion Pharmaceuticals, Inc. 8
Post-approval studies (Phase 4)WithdrawnNCT02292966
What this trial is testing

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism

Who this might be right for
Hepatitis C, Chronic
Kirby Institute
Large-scale testing (Phase 3)Study completedNCT00001729
What this trial is testing

Combination Drug Therapy for Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis CFibrosisHemolytic Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 120
Large-scale testing (Phase 3)Looking for participantsNCT05319353
What this trial is testing

Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Who this might be right for
Cytomegalovirus (CMV)
Takeda 80
Large-scale testing (Phase 3)Study completedNCT05446857
What this trial is testing

Glecaprevir/Pibrentasvir for the Treatment of PTSD

Who this might be right for
PTSD
White River Junction Veterans Affairs Medical Center 10
Large-scale testing (Phase 3)Study completedNCT06455007
What this trial is testing

Propolis as a Treatment Option for Hand Foot and Mouth Disease

Who this might be right for
Children Diagnosed With HMFDPropolis Antiviral Activity
Murat Sutcu 200
Post-approval studies (Phase 4)Study completedNCT01743521
What this trial is testing

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 14
Large-scale testing (Phase 3)Study completedNCT02383108
What this trial is testing

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children

Who this might be right for
HIV Infection
PENTA Foundation 318
Not applicableLooking for participantsNCT04439916
What this trial is testing

Breakthrough CMV Lung Transplant -Multicentre

Who this might be right for
Cytomegalovirus Infections
University of Alberta 40
Not applicableStudy completedNCT01623778
What this trial is testing

Optimization of Antiviral Therapy of Chronic HBV Infection

Who this might be right for
Australia Antigen PositiveHepatitis BAdverse Effects
Changhai Hospital 67
Early research (Phase 1)Study completedNCT03875209
What this trial is testing

10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV-1-infection
David Ho 54
Large-scale testing (Phase 3)Study completedNCT00006164
What this trial is testing

Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment

Who this might be right for
Chronic Hepatitis cCirrhosis, LiverFibrosis, Liver+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,050
Testing effectiveness (Phase 2)Study completedNCT02710604
What this trial is testing

Phase 2, Multiple Ascending Dose Proof of Concept Study

Who this might be right for
Infectious Disease
ContraVir Pharmaceuticals, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT04871113
What this trial is testing

Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

Who this might be right for
HIV Infections
ViiV Healthcare 62
Post-approval studies (Phase 4)Study completedNCT04340388
What this trial is testing

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Who this might be right for
HIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more
Augusta University 10
Not applicableStudy completedNCT04047680
What this trial is testing

EGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

Who this might be right for
Hepatitis CRenal DiseaseViral Hepatitis C
National Taiwan University Hospital 441
Next Page